Vasomotor symptoms and cardiovascular risk

References

• Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995; 38: 199–210
   PubMed Web of Science ®Google Scholar
• Grodstein F, Manson J E, Colditz G A, Willett W C, Speizer F E, Stampfer M J. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000; 133: 933–941
   PubMed Web of Science ®Google Scholar
• Stampfer M J, Colditz G A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47–63
   PubMed Web of Science ®Google Scholar
• Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605–613
   PubMed Web of Science ®Google Scholar
• Rossouw J E, Anderson G, Prentice R L, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• Manson J E, Allison M A, Rossouw J E, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007; 356: 2591–2602
   PubMed Web of Science ®Google Scholar
• Rossouw J E, Prentice R L, Manson J E, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297: 1465–1477
   PubMed Web of Science ®Google Scholar
• Gambacciani M. New HRT options for the treatment of menopausal symptoms and the maintenance of quality of life in postmenopausal women. Endocrine 2004; 24: 231–238
   PubMed Web of Science ®Google Scholar
• Leal M, Diaz J, Serrano E, Abellan J, Carbonell L F. Hormone replacement therapy for oxidative stress in postmenopausal women with hot flushes. Obstet Gynecol 2000; 95: 804–809
   PubMed Web of Science ®Google Scholar
• van der Schouw Y T, Grobbee D E. Menopausal complaints, oestrogens, and heart disease risk: an explanation for discrepant findings on the benefits of post-menopausal hormone therapy. Eur Heart J 2005; 26: 1358–1361
   PubMed Web of Science ®Google Scholar
• Gast G C, Grobbee D E, Pop V J, et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension 2008; 51: 1492–1498
   PubMed Web of Science ®Google Scholar
• Thurston R C, Sutton-Tyrrell K, Everson-Rose S A, Hess R, Matthews K A. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation 2008; 118: 1234–1240
   PubMed Web of Science ®Google Scholar
• Brown D, Sievert L L, Aki S L, et al. Effects of age, ethnicity and menopause on ambulatory blood pressure: Japanese-American and Caucasian school teachers in Hawaii. Am J Hum Biol 2001; 13: 486–493
   PubMed Web of Science ®Google Scholar
• Gerber L M, Sievert L L, Warren K, Pickering T G, Schwartz J E. Hot flashes are associated with increased ambulatory systolic blood pressure. Menopause 2007; 14: 308–315
   PubMed Web of Science ®Google Scholar
• MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–774
   PubMed Web of Science ®Google Scholar
• World Health Report 2002. Reducing Risks, Promoting Healthy Life. World Health Organization, GenevaSwitzerland 2002, Available at: http://www.who.int/whr/2002
   Google Scholar
• Villecco A S, de Aloysio D, Pilati G, et al. Non-invasive 24-hr monitoring of high blood pressure in climacteric outpatients. Maturitas 1987; 9: 267–274
   PubMed Web of Science ®Google Scholar
• Owens J F, Stoney C M, Matthews K A. Menopause status influences ambulatory blood pressure levels and blood pressure changes during mental stress. Circulation 1993; 88: 2794–2802
   PubMed Web of Science ®Google Scholar
• Staessen J A, Ginocchio G, Thijs L, Fagard R. Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens 1997; 11: 507–514
   PubMed Web of Science ®Google Scholar
• Tremollieres F A, Pouilles J-M, Cauneille C, Ribot C. Coronary heart disease risk factors and menopause: a study in 1684 French women. Atherosclerosis 1999; 142: 415–423
   PubMed Web of Science ®Google Scholar
• Matthews K A, Meilahn E, Kuller L H, Kelsey S F, Caggiula A W, Wing R R. Menopause and risk factors for coronary heart disease. N Engl J Med 1989; 321: 641–646
   PubMed Web of Science ®Google Scholar
• Van Beresteijn E C, Riedstra M, van der Wel A, Schouten E G, Burema J, Kok F J. Habitual dietary calcium intake and blood pressure change around the menopause: a longitudinal study. Int J Epidemiol 1992; 21: 683–689
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Pansini F, Manfredini R, Mollica G. Relative influence of menopausal status, age and body mass index on blood pressure. Hypertension 1997; 29: 976–979
   PubMed Web of Science ®Google Scholar
• Reckelhoff J F, Fortepiani L A. Novel mechanisms responsible for postmenopausal hypertension. Hypertension 2004; 43: 918–923
   PubMed Web of Science ®Google Scholar
• Freedman R R, Woodward S, Sabharwal S C. α2-Adrenergic mechanism in menopausal hot flashes. Obstet Gynecol 1990; 76: 573–578
   PubMed Web of Science ®Google Scholar
• Freedman R R. Physiology of hot flashes. Am J Hum Biol 2001; 13: 453–464
   PubMed Web of Science ®Google Scholar
• Freedman R R. Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. Fertil Steril 1998; 70: 332–337
   PubMed Web of Science ®Google Scholar
• Martin K A, Manson J E. Approach to the patient with menopausal symptoms. J Clin Endocrinol Metab 2008; 93: 4567–4575
   PubMed Web of Science ®Google Scholar
• Utian W H, Archer D F, Bachmann G S, et al. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of the North American Menopause Society. Menopause 2008; 15: 584–602
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. Estrogen and progestogen therapy in postmenopausal women. Fertil Steril 2008; 90(Suppl 5)S88–102
   Google Scholar
• American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease. Obstet Gynecol 2008; 112: 1189–1192
   PubMedGoogle Scholar
• Gompel A, Rozenberg S, Barlow D H, et al. The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy. Maturitas 2008; 61: 227–232
   PubMed Web of Science ®Google Scholar
• Pines A, Sturdee D W, Birkhäuser M H, et al. For the Board of the International Menopause Society IMS updated recommendations on postmenopausal hormone therapy. Climacteric 2007; 10: 181–194
   PubMed Web of Science ®Google Scholar